Pharming Group N.V. (PHAR) Earnings
|
Expand Research on PHAR
| Next EPS Date | 11/5/26 | EPS Growth Rate | +1,500.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -50.0% | Revenue Growth Rate | +9.0% |
| Average % Move 1-Wk after EPS | +3.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | $0.16 | N/A | N/A | $106.05M | N/A | N/A | N/A | ||
| 7/30/26 | Q226 | $0.00 | $0.06 | -$0.06 | $90.2M | $101.28M | N/A |  | | Details | |
| 5/7/26 |
Q126 | N/A | $0.01 | N/A | N/A | $93.75M | N/A | N/A | N/A | ||
| 3/12/26 |
Q425 | N/A | $0.05 | N/A | N/A | $101.76M | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | $0.01 | $0.00 | +$0.01 | $97.3M | $98.22M | N/A | | | Details | |
| 7/31/25 |
Q225 | N/A | -$0.01 | N/A | N/A | $78.95M | N/A | N/A | N/A | ||
| 5/9/25 |
Q125 | -$0.02 | -$0.01 | -$0.01 | $79.09M | $64M | N/A | | | Details | |
| 3/13/25 |
Q424 | N/A | -$0.02 | N/A | N/A | $159.02M | = | N/A | N/A |
